C. Lascoux

775 total citations
12 papers, 424 citations indexed

About

C. Lascoux is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, C. Lascoux has authored 12 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Virology and 3 papers in Epidemiology. Recurrent topics in C. Lascoux's work include HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (6 papers). C. Lascoux is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (6 papers). C. Lascoux collaborates with scholars based in France, Martinique and Canada. C. Lascoux's co-authors include D. Séréni, A. Bourgarit, Brigitte Autran, Éric Vicaut, V. Delcey, Philippe Lagrange, Guislaine Carcelain, Brigitte Gicquel, Valérie Martinez and Y. Bourezane and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Journal of Investigative Dermatology.

In The Last Decade

C. Lascoux

12 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Lascoux France	8	244	211	172	113	55	12	424
Amrit Singh United States	5	133 0.5×	107 0.5×	81 0.5×	131 1.2×	17 0.3×	11	341
Andrew Lim Australia	14	239 1.0×	331 1.6×	140 0.8×	174 1.5×	21 0.4×	25	592
Bindu Raju United States	9	212 0.9×	176 0.8×	69 0.4×	57 0.5×	28 0.5×	10	334
Anbalagan Selvaraj India	9	135 0.6×	146 0.7×	134 0.8×	47 0.4×	16 0.3×	14	300
Pascaline Tisserand France	12	206 0.8×	135 0.6×	134 0.8×	227 2.0×	38 0.7×	19	541
Niamh M. Keane Australia	14	107 0.4×	201 1.0×	67 0.4×	197 1.7×	34 0.6×	17	561
S Giosuè Italy	10	283 1.2×	208 1.0×	100 0.6×	31 0.3×	68 1.2×	12	449
O. Lambotte France	8	144 0.6×	56 0.3×	48 0.3×	168 1.5×	23 0.4×	25	377
M Casarini Italy	7	263 1.1×	189 0.9×	86 0.5×	30 0.3×	60 1.1×	8	394
Daniel Carrasco United States	12	45 0.2×	170 0.8×	70 0.4×	41 0.4×	37 0.7×	27	331

Countries citing papers authored by C. Lascoux

Since Specialization

Citations

This map shows the geographic impact of C. Lascoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lascoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lascoux more than expected).

Fields of papers citing papers by C. Lascoux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lascoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lascoux. The network helps show where C. Lascoux may publish in the future.

Co-authorship network of co-authors of C. Lascoux

This figure shows the co-authorship network connecting the top 25 collaborators of C. Lascoux. A scholar is included among the top collaborators of C. Lascoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Lascoux. C. Lascoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Chéret, Antoine, Rebecca Bauer, Vincent Meiffrédy, et al.. (2022). Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial. Journal of Antimicrobial Chemotherapy. 77(9). 2506–2515. 7 indexed citations

Castro, Nathalie De, Antoine Guéguen, C. Lascoux, et al.. (2016). Treatment with adalimumab for severe immune reconstitution inflammatory syndrome in an HIV-infected patient presenting with cryptococcal meningitis. Médecine et Maladies Infectieuses. 46(3). 154–156. 13 indexed citations

Galimand, Julie, Pierre Frange, Christine Rouzioux, et al.. (2010). Short Communication: Evidence of HIV Type 1 Complex and Second Generation Recombinant Strains Among Patients Infected in 1997–2007 in France: ANRS CO06 PRIMO Cohort. AIDS Research and Human Retroviruses. 26(6). 645–651. 16 indexed citations

Amrouche, Lucile, J.M. Gornet, C. Lascoux, et al.. (2009). De la fibrose rétropéritonéale à la linite gastrique. La Revue de Médecine Interne. 30(5). 443–445. 4 indexed citations

Bourgarit, A., Guislaine Carcelain, Valérie Martinez, et al.. (2006). Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS. 20(2). F1–F7. 231 indexed citations

Moulignier, Antoine, C. Lascoux, & A. Bourgarit. (2006). HIV Type 2 Demyelinating Encephalomyelitis. Clinical Infectious Diseases. 42(11). e89–e91. 8 indexed citations

Fournier, S., Cendrine Chaffaut, Anne Maillard, et al.. (2005). Factors associated with virological response in HIV‐infected patients failing antiretroviral therapy: a prospective cohort study. HIV Medicine. 6(2). 129–134. 6 indexed citations

Séréni, D. & C. Lascoux. (2001). Recent developments in the treatment of HIV disease. European Journal of Internal Medicine. 12(4). 322–326. 1 indexed citations

Pellet, C, Sylvie Chevret, L. Blum, et al.. (2001). Virologic and Immunologic Parameters that Predict Clinical Response of AIDS-Associated Kaposi's Sarcoma to Highly Active Antiretroviral Therapy. Journal of Investigative Dermatology. 117(4). 858–863. 45 indexed citations

10.

Hoen, Bruno, M Harzic, Alain Venet, et al.. (1999). Highly Active Antiretroviral Treatment Initiated Early in the Course of Symptomatic Primary HIV‐1 Infection: Results of the ANRS 053 Trial. The Journal of Infectious Diseases. 180(4). 1342–1346. 57 indexed citations

11.

Séréni, D., Roland Tubiana, C. Lascoux, et al.. (1999). Pharmacokinetics and Tolerability of Intravenous Trecovirsen (GEM®91), an Antisense Phosphorothioate Oligonucleotide, in HIV‐Positive Subjects. The Journal of Clinical Pharmacology. 39(1). 47–54. 35 indexed citations

12.

Katlama, Christine, et al.. (1994). Phase I study of single intravenous and subcutaneous ascending doses of GEM 91 in HIV positive, asymptomatic volunteers. AIDS. 8(Supplement 4). S33–S33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact